AVITA Medical Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, AVITA Medical stock has a consensus rating of "Buy" and an average price target of $8.99. The average 1-year stock price forecast is 77.84% higher than the current stock price, while the lowest is $5.99 (+18.50%) and the highest is $11.99 (+137.19%).

Price Target: $8.99 (+77.84%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$5.99	$8.99	$8.99	$11.99
Change	+18.50%	+77.84%	+77.84%	+137.19%

Analyst Ratings

The average analyst rating for AVITA Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	3	3	3	2
Buy	0	0	0	0	0	0
Hold	2	2	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	1	0	0	0	0	0
Total	6	5	5	5	4	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Josh Jennings TD Cowen	TD Cowen	Buy Maintains $5.5 → $12	Buy	Maintains	$5.5 → $12	+137.39%	Jun 30, 2026
Frank Takkinen Lake Street	Lake Street	Buy Reiterates $6	Buy	Reiterates	$6	+18.69%	Jun 26, 2026
Ryan Zimmerman BTIG	BTIG	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jun 23, 2026
Carl Byrnes Northland Securities	Northland Securities	Buy Maintains $10	Buy	Maintains	$10	+97.82%	Mar 26, 2026

Financial Forecast

Revenue This Year

83.41M

from 71.61M

16.47%

from 71.61M

Revenue Next Year

107.27M

from 83.41M

28.61%

from 83.41M

EPS This Year

-1.03

from -1.74

EPS Next Year

-0.60

from -1.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	33.03M	34.42M	50.14M	64.25M	71.61M	83.41M
Revenue Growth	12.98%	4.23%	45.68%	28.14%	11.45%	16.47%
Gross Profit	26.92M	28.38M	42.36M	55.16M	58.82M	68.53M
Gross Margin	81.52%	82.45%	84.48%	85.85%	82.13%	82.17%
Operating Income	-25.08M	-27.51M	-42.66M	-56.59M	-42.53M	-29.29M
Net Income	-25.14M	-26.67M	-35.38M	-61.85M	-48.59M	-34.81M
EPS	-	-	-	-	-1.74	-1.03
Free Cash Flow	-	-9.31M	-24.56M	-32.64M	-18.33M	-30.23M
No. Analysts	-	-	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	87.2M
Avg	83.4M
Low	80.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	21.7%
Avg	16.5%
Low	11.7%

EPS Forecast

EPS	2026	2027	2028
High	-0.67
Avg	-1.03
Low	-1.29

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-